Skip to search formSkip to main contentSkip to account menu

acifran

Known as: 2-Furancarboxylic acid, 4,5-dihydro-5-methyl-4-oxo-5-phenyl-, 2-methyl-2-phenyl-3(2H)furanone-5-carboxylic acid, 4,5-dihydro-5-methy1-4-oxo-5-pheny1-2-furancarboxylic acid 
An agonist of niacin receptors capable of mimicking niacin's ability to increase high-density lipoprotein (HDL). Acifran produces these effects at… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
In this study, we present the identification and characterization of hamster and guinea pig nicotinic acid receptors. The hamster… 
1990
1990
The pharmacokinetics and metabolic fate of the antihyperlipidemic drug acifran were assessed after a single oral dose of the 14C… 
1987
1987
The antihyperlipoproteinemic agent acifran (AY-25,712) was administered double-blind to 14 Type IIa hyperlipoproteinemic patients… 
1986
1986
The metabolic disposition of the antihyperlipidemic agent acifran (AY-25, 712) was determined in rats and dogs. The synthesis of…